Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy. (30th November 2021)

Record Type:: Journal Article
Title:: Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy. (30th November 2021)
Main Title:: Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy
Authors:: Okada, Yuri
Izumi, Rumiko
Hosaka, Tatsuhiko
Watanabe, Satoshi
Shijo, Tomomi
Hatchome, Naokazu
Konishi, Risa
Ichimura, Yuki
Okiyama, Naoko
Suzuki, Naoki
Misu, Tatsuro
Aoki, Masashi
Abstract:
Is Part Of:: Rheumatology. Volume 61:Number 4(2022)
Journal:: Rheumatology
Issue:: Volume 61:Number 4(2022)
Issue Display:: Volume 61, Issue 4 (2022)
Year:: 2022
Volume:: 61
Issue:: 4
Issue Sort Value:: 2022-0061-0004-0000
Page Start:: e90
Page End:: e92
Publication Date:: 2021-11-30
Subjects:: Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005
Journal URLs:: http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
DOI:: 10.1093/rheumatology/keab872 ↗
Languages:: English
ISSNs:: 1462-0324
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21260.xml